Elevated pressure in the pancreatic gland is the central cause of pancreatitis following abdominal trauma, surgery, endoscopic retrograde cholangiopancreatography (ERCP), and gallstones. In the pancreas excessive intracellular calcium causes mitochondrial dysfunction, premature zymogen activation, and necrosis ultimately leading to pancreatitis. Although stimulation of the mechanically activated, calcium-permeable ion channel, Piezo1, in the pancreatic acinar cell is the initial step in pressure-induced pancreatitis, activation of Piezo1 produces only transient elevation in intracellular calcium that is insufficient to cause pancreatitis. Therefore, how pressure produces a prolonged calcium elevation necessary to induce pancreatitis is unknown. We demonstrate that Piezo1 activation in pancreatic acinar cells caused a prolonged elevation in intracellular calcium levels, mitochondrial depolarization, intracellular trypsin activation, and cell death. Notably, these effects were dependent on the degree and duration of force applied to the cell. Low or transient force were insufficient to activate these pathological changes whereas higher and prolonged application of force triggered sustained elevation in intracellular calcium leading to enzyme activation and cell death. All of these pathological events were rescued in acinar cells treated with a Piezo1 antagonist and in acinar cells from mice with genetic deletion of Piezo1. We discovered that Piezo1 stimulation triggered TRPV4 channel opening which was responsible for the sustained elevation in intracellular calcium that caused intracellular organelle dysfunction. Moreover, TRPV4 gene knockout mice were protected from Piezo1 agonist-and pressure-induced pancreatitis. These studies unveil a calcium signaling pathway in which Piezo1-induced TRPV4 channel opening causes pancreatitis.
Introduction
The pancreas is highly sensitive to pressure (1) (2) (3) and elevated pancreatic duct pressure is a major cause of acute pancreatitis. A gallstone impacted at the junction of the pancreatic and common bile ducts increases pancreatic duct pressure and can initiate pancreatitis (4-6). Intraductal pancreatic pressure is also increased during the clinical procedure endoscopic retrograde cholangiopancreatography (ERCP) when radiocontrast dye is injected into the pancreatic duct to visualize the pancreas (7) .
Acute pancreatitis develops in up to 20% of high risk patients undergoing this procedure (8) . Mechanical injury to the pancreas through abdominal trauma is also a common cause of pancreatitis (9) . Recently, our group demonstrated that the pancreatic acinar cell senses pressure through the mechanically-activated ion channel Piezo1 and activation of Piezo1 on acinar cells by pressure or a Piezo1-specific agonist, induced acute pancreatitis (1) . Moreover, mice with acinar cell-specific deletion of Piezo1 were protected from pressure-induced pancreatitis. Thus, mechanical activation of Piezo1 is sufficient to cause pancreatitis.
Mechanical forces including static pressure, fluid shear stress, and membrane stretch activate Piezo1 channel opening which allow cations, most notably Ca 2+ , to flow into the cell (10) (11) (12) (13) (14) . Recently, Yoda1, a pharmacological agonist selective for Piezo1 but not Piezo2, has been identified (15) . Piezo1 is expressed in numerous tissues that respond to shear force including the vascular endothelium, lung, skin, and urinary bladder (16, 17) . Studying the signaling of Piezo1 in the pancreas offers an attractive model for unveiling the pathological response because of the uniquely sensitive behavior of pancreatic acinar cells to alterations in intracellular calcium levels.
Intracellular Ca 2+ concentrations are tightly regulated in pancreatic acinar cells and provide the major signal for digestive enzyme secretion (18, 19) . Cholecystokinin (CCK), acetylcholine and bombesin are pancreatic secretagogues that raise cytosolic calcium ([Ca 2+ ]i) and thus stimulate secretion (20) (21) (22) . Binding of these agonists to their respective G-protein coupled receptors triggers the release of Ca 2+ from the endoplasmic reticulum (ER) through increased activity of phosphoinositide-specific phospholipase C that cleaves phosphatidylinositol, 4,5-bisphosphate (PIP2) to inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (23) . Notably, this Ca 2+ rise is necessary for normal cell signaling. Perturbation of Ca 2+ signaling is associated with pancreatic acinar cell death (23) . Supramaximal concentrations of agonists such as CCK lead to activation of calcium release activated channels (CRAC) in the plasma membrane (24) resulting in a sustained elevation in [Ca 2+ ]i and intracellular activation of proenzymes in pancreatic acinar cells that ultimately leads to cell death (24) . Due to their intensive protein synthesis, acinar cells have high energy requirements and mitochondrial demands.
Mitochondrial dysfunction can lead to impairment in energy requiring processes including proenzyme sorting, intracellular lysosome and zymogen vesicle formation and stability, and cellular integrity (25) . Disruption of any of these functions can lead to pancreatitis. Calcium overload causes opening of the mitochondrial permeability transition pore (MPTP), collapses the mitochondrial membrane potential and disrupts the proton gradient necessary for ATP production which is required to satisfy the high energy demands of the acinar cell (25) (26) (27) (28) (29) . Therefore, maintenance of proper mitochondrial function is necessary to prevent pancreatitis.
The calcium permeable ion channel, transient receptor potential vanilloid subfamily 4 (TRPV4), is expressed in various tissues and cells (e.g., smooth muscle of the urinary bladder, epithelial cells of kidney, airways, sensory neurons, and vascular endothelium) and is involved in several physiological processes and diseases including regulation of blood flow, shear-induced vasodilation and epithelial ciliary activity (30-37). TRPV4-mediated pathological events include neurogenic inflammation, hyperalgesia, endothelial dysfunction, and pulmonary and cardiac tissue fibrosis (33, 36, (38) (39) (40) . TRPV4 may be activated by physical force (e.g., shear stress, membrane stretching) and hypotonic cell swelling but this sensing appears to be indirect (41, 42) . However, the mechanism by which these physical forces activate TRPV4 is not clear.
Hypotonic cell swelling and shear stress stimulate phospholipase A2 (PLA2) activity (42) . In general, elevated phospholipase A2 activity triggers the release of arachidonic acid (AA) and its metabolite, 5', 6'-epoxyeicosatrienoic acid (5',6'-EET) (43) . 5 ', 6'-EET is an endogenous ligand that can activate TRPV4 (43) . However, the mechanism by which physical stimuli activate PLA2 is not known. Phosphorylation of protein kinase A (PKA) and protein kinase C (PKC) increase the sensitization of TRPV4 (44, 45) therefore, it is possible that activation of TRPV4 through arachidonic acid may require PKA or PKC phosphorylation (44) .
Here, we demonstrate that activation of Piezo1 in pancreatic acinar cells by direct chemical stimulation and fluid shear stress produced a sustained increase in cytosolic Ca 2+ , followed by mitochondrial depolarization, and premature trypsinogen activation.
Moreover, Piezo1-induced Ca 2+ signaling is distinctly different from CCK-induced Ca 2+ signaling suggesting that multiple pathways may contribute to the initiation of pancreatitis. To explain how Piezo1 activation led to sustained and pathological elevation in [Ca 2+ ]i, we explored other potential calcium entry pathways and discovered that both mouse and human pancreatic acinar cells express the calcium permeable channel TRPV4. We also demonstrate that Piezo1 induced the activation of PLA2 which causes TRPV4 channel opening.
Results

Piezo1 induces sustained cytoplasmic Ca 2+ elevation and cell death
In order to determine whether calcium signaling is responsible for the effects of Piezo1 on the pancreas, we first examined the ability of the chemical Piezo1 agonist Yoda1 to regulate intracellular calcium ([Ca 2+ ]i) in freshly isolated pancreatic acini.
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Changes in [Ca 2+ ]i were determined in acinar cells loaded with the calcium indicator Calcium 6-QF. We recently reported that the Piezo1 antagonist GsMTx4 inhibits the Yoda1-mediated [Ca 2+ ]i rise in pancreatic acini (1, 46) . Here, we demonstrate the contribution of external and intracellular free calcium on Piezo1-mediated [Ca 2+ ]i. Yoda1 in the presence of bath calcium (2 mM) produced an initial transient Ca 2+ rise followed by sustained intracellular calcium elevation ( Figure 1A and B and Movie 1).
Removal of external calcium completely abolished the Yoda1-mediated [Ca 2+ ]i rise ( Figure 1A To examine the effect of sustained Piezo1 activation on [Ca 2+ ]i and its relation to cellular injury, we treated pancreatic acini with Yoda1 and cellular injury was assessed by measuring lactate dehydrogenase (LDH) release. Cells were pre-incubated with or without BAPTA-AM. Chelating intracellular free calcium with BAPTA-AM protected pancreatic acini from Yoda1-induced LDH release ( Figure 1F ). We confirmed the specificity of these effects for Piezo1 by comparing the cytotoxic effects of CCK ( Figure   1E ). At high concentrations, CCK is well known to cause cell damage in vitro and pancreatitis in vivo (47, 48) . As shown in Figure 1E , CCK produced comparable cell damage in pancreatic acini from both wild type mice and mice with selective genetic deletion of Piezo1 in pancreatic acinar cells (Piezo aci KO) mice (1) . We visualized the effect of Yoda1 on pancreatic acini over time by live cell imaging. Application of Yoda1 (50 µM) caused swelling of wild type pancreatic acinar cells, release of zymogen granules from the basolateral surface and gradually ruptured the cell membrane ( Figure  1G , Movie 2). Pancreatic acinar cells from Piezo1 aci KO mice did not respond to Yoda1 (Movie 3).
In pancreatic acinar cells, CCK at supraphysiological concentrations produces a sustained elevation of [Ca 2+ ]i, the initial phase of which is due to release of Ca 2+ from the endoplasmic reticulum (ER) (23) . Following this initial rise, the sustained phase occurs through the activation of calcium release-activated channels (CRAC) which allows extracellular Ca 2+ to flow into cells. In order to determine if the Piezo1-mediated sustained [Ca 2+ ]i elevation is due to CRAC activation, we examined the effects of the CRAC inhibitor, CM4620, which selectively inhibits Orai, the main component of CRAC (49) . Pre-incubating acinar cells with CM4620 for 1 hour blocked the sustained elevation in [Ca 2+ ]i produced by CCK (100 and 1,000 pM) (Supplemental Figure S2A -C).
Notably, CM4620 did not completely block the [Ca 2+ ]i rise induced by either concentration of CCK and a residual calcium wave was always observed following CCK despite CM4620 administration (Supplemental Figure S2A -C). This persistent calcium wave was possibly due to Ca 2+ released from endoplasmic reticulum (ER) stores (50, 51) . In contrast to the effects on CCK-stimulated [Ca 2+ ]i, CM4620 did not alter the rise in [Ca 2+ ]i following Yoda1 stimulation (Supplemental Figure S2D Figure S3A -D). In order to confirm that Piezo1 and CCK stimulate [Ca 2+ ]i through distinct mechanisms, we first activated Piezo1 channels in pancreatic acini through mechanical force by applying a blunt glass pipette to the surface of acinar cells to a depth of 5 µm for 1 second. This blunt pushing produced a transient [Ca 2+ ]i elevation. Cells were then exposed to CCK (20 pM). Slight mechanical pushing did not alter the sensitivity of pancreatic acini to subsequent CCK exposure (Supplemental Figure S3E and F). In light of the finding that Piezo1 and CCK affect [Ca 2+ ]i. through separate pathways, we sought to determine if together Yoda1 and CCK accentuated the deleterious effects on pancreatic acinar cells. Compared to individual application of Yoda1 and CCK, acinar cell death was greater when cells were exposed to both Yoda1 and CCK (Supplemental Figure S3G and H).
Piezo1 agonist, Yoda1, induces pathological events in pancreatic acini
Pancreatic acinar cells possess abundant mitochondria and are highly metabolically active. Proper mitochondrial function is critical for cellular homeostasis and mitochondrial dysfunction has been implicated in the pathogenesis of pancreatitis.
We postulated that the elevations in cytoplasmic [Ca 2+ ] that were observed with Yoda1 stimulation and Piezo1 activation in pancreatic acinar cells may affect mitochondrial depolarization. To test this hypothesis, we used a cell-permeable and mitochondrial potential-sensitive fluorescent dye, tetramethyl rhodamine ester (TMRE) (52, 53) . Figure 2B and C). Pancreatic acinar cells pre-incubated with BAPTA-AM for 20 minutes were protected from Yoda1-induced mitochondrial depolarization, suggesting a significant role for intracellular free calcium ( Figure 2E ). We observed that Yoda1-induced mitochondrial depolarization occurred at a higher rate than that induced with CCK (10 nM) (Figure 2A have been associated with intracellular trypsinogen activation (52, 54) . We postulated that prolonged activation of Piezo1 may cause trypsinogen activation through a calcium-mediated pathway. We visualized real-time trypsinogen activation in pancreatic acini using a trypsin-sensitive, cell-permeable fluorescent probe, BZiPAR, that becomes fluorescent once it is cleaved specifically by trypsin (52, 55) . Application of either Yoda1 (50 µM) or CCK (10 nM) activated trypsin in pancreatic acini over time ( Figure 2F and G and Movie 4). Yoda1 induced trypsin activation within 10 minutes of application, however CCK stimulated trypsin activation more slowly and was observed only after 20 minutes of drug exposure (Movie 4). GSMTx4 blocked the Yoda1-induced trypsin activation in pancreatic acinar cells ( Figure 2H ). Pancreatic acinar cells from Piezo1 aci KO mice did not respond to Yoda1 ( Figure 2H ). Furthermore, CCK mediated trypsin activation was similar in acini from wild type and Piezo1 aci KO mice ( Figure 2I ).
Mechanical pushing-and shear stress-induced [Ca 2+ ]i elevation in pancreatic acini
Mechanical activation of Piezo1 in acinar cells was demonstrated by applying a blunt glass pipette to the surface of acinar cells to a depth of 5 µm for 1 second. This stimulation produced a transient [Ca 2+ ]i rise ( Figure 3A and B and Movie 5) that was completely blocked by prior treatment of the cells with GsMTx4 ( Figure 3C ). In addition, mechanical pushing did not increase [Ca 2+ ]i in acinar cells from Piezo1 aci KO mice ( Figure 3C and Movie 6). Removal of external calcium blocked the mechanical pushing-mediated [Ca 2+ ]i rise ( Figure 3D ). In order to apply physical force for a longer time, we used a fluid shear stress approach to avoid cell damage that might occur with repeated mechanical pushing and other technical difficulties. The fluid shear stress approach is similar to the situation in which high fluid pressure is injected into the pancreatic duct as we have demonstrated (1) which has been used as a model for the clinical condition of excess filling of the pancreatic duct in humans during endoscopic retrograde cholangiopancreatography (ERCP) (7) .
Mechanical shear stress is a physiological activator of Piezo1 in many tissues including vascular endothelium (12, 13) . To determine if Piezo1 channels are responding to fluid shear stress in the pancreas, we evaluated changes in [Ca 2+ ]i in freshly isolated pancreatic acini plated in a shear flow chamber (13) . Following a period as brief as 30 seconds, the peak intensity of [Ca 2+ ]i in pancreatic acini increased as greater shear stress forces were applied ( Figure 3E 
Fluid shear stress induces pathological events in pancreatic acini
To determine whether fluid shear stress-activated Piezo1 facilitates mitochondrial depolarization, we monitored live cell mitochondrial depolarization in pancreatic acini loaded with the mitochondrial sequestrant dye, TMRE (200 nM), from wild type and Piezo1 aci KO mice. Fluid shear stress administered at 12 dyne/cm 2 for 30 seconds that caused a sustained elevation in [Ca 2+ ]i decreased the TMRE intensity over time in wild type pancreatic acini but not in Piezo1 aci KO cells ( Figure 4A Pancreatic acini were then subjected to fluid shear stress at 12 dyne/cm 2 for 30 seconds.
Trypsin activity monitored by live cell imaging was detected after 10 minutes of fluid shear stress and gradually increased for up to 50 minutes ( Figure 4C ). An increase in BZiPAR dye (trypsin activity) was not observed in Piezo1 aci KO cells. In contrast, however, a short pulse of 5 seconds, instead of 30 seconds, at a force of 12 dyne/cm 2 did not trigger trypsin activation in wild type acinar cells ( Figure 4D ). As we observed with mitochondrial depolarization, brief mechanical pushing of pancreatic acinar cells was not sufficient to activate trypsin (Supplemental Figure S4B ).
Piezo1 mediates TRPV4 channel activation in pancreatic acini
Although Piezo1 is a fast inactivating channel, fluid shear stress and Yoda1 caused a sustained elevation in [Ca 2+ ]i raising the possibility that other calcium entry channels or Piezo1-mediated downstream signaling pathways may exist. CRAC which is expressed in pancreatic acinar cells (24) was one possibility, however, we observed that the CRAC inhibitor CM4620, which selectively inhibits the Orai channel, blocked the sustained elevation in [Ca 2+ ]i produced by CCK but not that induced by Yoda1 ( Figure S2 ). Therefore, it is unlikely that CRAC contributes to Piezo1-stimulated Ca 2+ entry. Since TRPV4 indirectly senses fluid shear stress, we sought to determine if TRPV4 was expressed in pancreatic acinar cells. As shown in Figure 5A and B, TRPV4 mRNA and protein were detected by RT qPCR and immunostaining, respectively.
Moreover, TRPV4 is highly expressed in both mouse and human pancreatic acini ( Figure 5A To determine the mechanism for TRPV4 activation, we examined the PLA2 pathway by first testing the endogenous arachidonic acid (AA) metabolite ligand 5, 6epoxyeicosatrienoic acid (5', 6'-EET). Similar to the TRPV4 agonist GSK101, AA and 5'- Figure 5I and J). Importantly, we discovered that neither Yoda1 nor fluid shear stress (12 dyne/ cm 2 for 30 sec) caused a sustained increase [Ca 2+ ]i in pancreatic acini isolated from TRPV4 KO mice ( Figure 5K and L). Together these findings indicate that Piezo1 directly senses fluid shear stress and initiates calcium influx. However, the activation of TRPV4 is responsible for the secondary sustained influx of calcium resulting in the sustained elevation in [Ca 2+ ]i.
Piezo1 elevates phospholipase A2 activity
TRPV4 is activated by 5'-6' EET generated through the PLA2-arachidonic acid cytochrome P450 epoxygenase dependent pathway (42) . If this pathway is responsible Protein kinase A and C inhibitors did not significantly affect Yoda-stimulated [Ca 2+ ]i (Supplemental Figure S6 ).
TRPV4 KO mice are protected against pressure-induced pancreatitis
Sustained elevations in [Ca 2+ ]i are sufficient to cause pancreatitis (60) . Having demonstrated that Piezo1-initiated, sustained [Ca 2+ ]i elevation requires TRPV4 activation, we proposed that TRPV4 KO mice could be protected from Piezo1-mediated pancreatitis. In order to selectively stimulate Piezo1 in the pancreas, Yoda1 (0.4 mg/kg) was infused into the pancreatic duct at a rate of 5 µL/min ( Figure 7A ). This rate of infusion did not exceed the pancreatic duct pressure of 11 mm Hg and is considered a low pressure condition (1) that alone does not cause pancreatitis. As shown in Figure   7B Having demonstrated that Piezo1 and CCK increase [Ca 2+ ]i through separate mechanisms, we proposed that CCK would not trigger TRPV4 channel opening. In support of this idea, we found that the TRPV4 channel blocker HC067 did not affect the CCK (1 nM) stimulated peak or sustained [Ca 2+ ]i changes (Supplemental Figure S7A Piezo1 is responsible for pressure-induced pancreatitis (1) . Experimentally, Piezo1 aci KO mice were protected against pancreatitis caused by high intrapancreatic duct pressure (1) . If the pathological effects of Piezo1 activation are due to the downstream activation of TRPV4, we would expect that mice lacking TRPV4 would be protected against pressure-induced pancreatitis. We induced pancreatitis by ligating the tail region of the pancreas up to 24 hours ( Figure 7G ). In wild type mice, pancreatic duct ligation caused acute tissue injury which was reflected by an increase in all pancreatitis parameters. In contrast, TRPV4 KO mice were protected against duct ligation-induced pancreatitis ( Figure 7H-L) . These findings confirm that TRPV4 plays a key role in pressure-induced pancreatitis.
Discussion
Acinar cells comprise 90% of the pancreas and are notable for their abundant digestive enzymes which render the gland highly susceptible to pancreatitis should enzymes become prematurely activated following organ damage. Intracellular enzyme activation is a hallmark of pancreatitis and is believed to play a central role in disease pathogenesis. Recently we demonstrated that pressure activation of Piezo1 channels in pancreatic acinar cells is responsible for pressure-induced pancreatitis (1) . Prior to the identification of Piezo1 in acinar cells, it was not known how the pancreas senses pressure although a number of pathological situations indicate that the gland is exquisitely sensitive to pressure-induced injury. For example, intrapancreatic duct pressure is increased by occlusion of the pancreatic duct (4-6) and this is thought to be a key factor in the development of gallstone-induced pancreatitis which is one of the major causes of acute pancreatitis in humans. In this disease, impaction of a gallstone in the ampulla of Vater causes an abrupt increase in pancreatic duct pressure leading to pancreatitis (61) . In addition, mechanical force on the pancreas during trauma or pancreatic surgery may cause pancreatitis (7, 9) . Finally, injection of fluid into the pancreatic duct at high pressure during ERCP is a well-known cause of pancreatitis (7, 62, 63) . In each of these causes of pancreatitis, abnormal pressure on the pancreas has the potential to activate Piezo1. However, Piezo1 is also expressed in other tissues where it mediates several physiological processes like micturition, endothelial shear stress, embryogenesis, and vascular development (12, 13, 16, 17, 64) . The question, therefore, arises how activation of the Piezo1 channel leads to the pathological process of pancreatitis? In general, under normal physiological conditions activation of Piezo1 channels is tightly regulated. Piezo1 channel function and transduction properties vary with stimulus frequency, waveform, and duration (65). We propose that overactivation of Piezo1 by persistent pressure or mechanical force in acinar cells produces downstream signaling events that disrupt normal cellular homeostasis resulting in premature enzyme activation and ultimately pancreatitis. In the pancreas, disruption of calcium homeostasis is detrimental and leads to pancreatitis (23, 66) .
Here, we demonstrated that either chemical (Yoda1) Under physiological conditions, the pancreatic secretagogues acetylcholine and CCK stimulate [Ca 2+ ]i in a spatiotemporal manner that is required for ATP production, initiation of exocytosis, and nuclear signaling processes (68) . However, supraphysiological CCK stimulation, excess ethanol, bile, and toxins induce a sustained elevation in [Ca 2+ ]i in pancreatic acinar cells that cause acute pancreatitis (28, (69) (70) (71) (72) .
This sustained elevation in [Ca 2+ ]i mediates mitochondrial dysfunction, premature zymogen activation, vacuolization and necrosis (73) . We observed that both Yoda1 and fluid shear stress induced mitochondrial depolarization and trypsin activation in pancreatic acinar cells. Transient depolarization of mitochondria following a rise in [Ca 2+ ]i is associated with normal cellular ATP production. However [Ca 2+ ]i overload in acinar cells induced by bile and ethanol (27, 28, 71, 74) opens the mitochondrial permeability transition pore (MPTP), collapses the mitochondrial membrane potential (ψm) required for ATP synthesis (75) (76) (77) , and ultimately results in cell death. By chelating intracellular free Ca 2+ , we prevented Yoda1-induced mitochondrial depolarization and cell death. It has been observed previously that intracellular calcium chelation prevents zymogen activation (52, 78) and protects against acute pancreatitis in vivo (79) . We observed that Piezo1-mediated mitochondrial depolarization preceded trypsin activation following either Yoda1 treatment or shear stress and is ultimately responsible for pressure-induced pancreatitis.
Piezo1 is a fast inactivating channel with single-channel conductance of ∼22 pS (inward current) which is lower than the TRPV4 ion channel of ∼60 pS (10, 80) . Piezo1 inactivation kinetics are independent of stimulus intensity (10) . If no other type of channels are present in the cell except Piezo1, the calcium rise will be transient rather than sustained due to fast inactivation kinetics. This suggests that the Piezo1-induced sustained elevation in [Ca 2+ ]i produced by Yoda1 or shear stress requires an extra calcium entry pathway. We, therefore, sought other potential channels that could be linked to Piezo1 activity and discovered that TRPV4 is expressed in both mouse and human pancreatic acini.
Initially, we thought that mechanical activation of Piezo1 and TRPV4 were independent processes. Even though activation of Piezo1 could produce a transient increase in [Ca 2+ ]i, and TRPV4 could produce more sustained elevation of [Ca 2+ ]i, by virtue of its slow inactivation kinetics and considerably higher single channel conductance, it was not clear if the two processes were linked. Remarkably, the TRPV4 antagonist HC067 completely blocked the sustained phase of calcium elevation induced by Yoda1 and shear stress. This provided the hint that Piezo1 regulates TRPV4 channel activation. The results were confirmed in experiments from TRPV4 KO mice when both Yoda1 and prolonged shear stress produced only transient elevation in [Ca 2+ ]i. Low shear stress for 30 seconds and high shear stress for 5 seconds were not sufficient to induce a sustained calcium rise and did not activate TRPV4. The reason could be the brief force caused only a subset of Piezo1 channel openings and was insufficient to activate PLA2. In the cell, PLA2 is activated upon binding to calcium ions that accelerates enzyme activity, which initiates the arachidonic pathway and TRPV4 channel activation. In mouse pancreatic acinar cells, the Piezo1 agonist, Yoda1 increased PLA2 activity and caused a sustained elevation in [Ca 2+ ]i, an effect that was inhibited by a PLA2 inhibitor. Various reports indicate that TRPV4 is sensitive to mechanical stimuli such as osmotic pressure, shear stress and mechanical stretching (31-37). However, it was unclear how mechanical stimuli actually activate the TRPV4 channel. The current findings indicate that Piezo1 stimulation of PLA2 and subsequent activation of TRPV4 could be a mechanism by which TRPV4 channels respond to mechanical force.
Supramaximal doses of CCK secretagogue block apical secretion and cause
intracellular vacuolization, enzyme activation and enzyme release from the basolateral surface of the cell (81, 82) . In the present study we observed that Yoda1 induced the release of vesicles from the basolateral surface indicating a possible pathological situation.
We did not observe any significant effects of PKA and PKC inhibitors on Yoda1mediated TRPV4 activation. In other cells such as HEK293 cells or human coronary artery endothelial cells, PKA and PKC can directly phosphorylate TRPV4 and modify channel activity. Our findings suggest that this pathway is not required for channel activation.
The current study demonstrates that Piezo1 initiates the pressure-induced calcium signal causing TRPV4 activation but the pathological events that occur in the acinar cell require TRPV4-mediated calcium influx which is responsible for the sustained phase of calcium elevation that leads to pancreatitis. Consistent with this pathological sequence of events, TRPV4 KO mice were protected from Yoda1-induced pancreatitis.
To mimic pancreatitis caused by pancreatic duct obstruction (e.g., gallstones), we used a mouse model of pancreatitis by ligating the tail region of the pancreas for 24 hours (83) . In this model, we observed that TRPV4 KO mice were significantly protected. Hence, a TRPV4 channel blocker could be a possible treatment for pancreatitis where pressure is encountered.
Our findings suggest the activation of Piezo1 in the absence of TRPV4 is not sufficient to induce pathological calcium signaling. However, when co-expressed and linked by intracellular signaling pathways, TRPV4 may appear to be pressure-sensitive.
For example, Piezo1 and TRPV4 channels are expressed in endothelial cells and previous reports have indicated that high pulmonary venous pressure induces Ca 2+ influx into endothelial cells via TRPV4 channels resulting in increased vascular permeability which is a major cause of mortality in heart failure patients (33). Although unrecognized at the time, this process may be linked to Piezo1 which appeared to sense high vascular pressures at the lung endothelial surface and account for vascular hyperpermeability and pulmonary edema (30). Thus, it appears that both Piezo1 and TRPV4 are responsible for this vascular hyperpermeability and our findings suggest that they may be linked. We hypothesize that Piezo1 sensing of high vascular pressure initiates a Ca 2+ signaling pathway that triggers the activation of TRPV4. TRPV4 activation would then cause a secondary, sustained Ca 2+ influx that would lead to vascular hyperpermeability. The extent of TRPV4-induced Ca 2+ entry would be influenced by other factors including the level of TRPV4 expression, the degree and duration of pressure, and, if identical to the pancreas, the appropriate level of PLA2 activity. Thus, our findings may represent a more generalized process in which TRPV4 converts Piezo1 pressure sensing into a pathological event. Pancreatic acini and acinar cell preparations. Mouse pancreatic acini were isolated using the standard collagenase digestion protocol as previously described (1, 86, 87) . Mechanical Pushing. A borosilicate glass pipette (Sutter Instrument) was pulled using a pipette puller P-87 (Sutter Instrument) and made blunt with a MF-900 Microforge (Narishige, Japan). Acini were pushed once with a 2-3 µm tip blunt pipette to 5 µm for 1 second using a micromanipulator (World Precision Instruments).
Methods
Animals. Targeted deletion of
Calcium Imaging. Calcium imaging in pancreatic acini were was performed as described previously (1) . The chemicals used in calcium imaging experiments included: Immunostaining. Pancreatic acini were incubated with a rabbit anti-TRPV4 antiserum (Alomone; #ACC-034; 1:250) or with a rabbit anti-Piezo1 antiserum (Alomone; # APC-087; 1:300) overnight at 2-8°C. The signals from TRPV4 and Piezo1 immunostaining were amplified by the tyramide signal amplification method using a kit (Life Technologies; #T20924) following the manufacturer's instructions. The nuclei were stained with Nunc blue (Invitrogen; R376060). All staining images were taken with a Zeiss Axio observer Z1 with a 20x objective or a ×63 oil-immersion objective.
In vivo pancreatitis models. Laparotomy surgery was performed both in pancreatic partial duct ligation and retrograde pancreatic duct infusion-mediated pancreatitis experiments as previously described (1) . Yoda1 at dose of 0.4 mg/kg in 50 μL was injected as previously described (1) . In Yoda1-mediated pancreatitis, the mid-portion of the pancreas (about 100-125 mg) was carefully excised and used for biochemical assays and histological staining. Histological scoring was evaluated from the entire section.
Partial pancreatic duct ligation (PDL) was done as previously described (89, 90) . Using a stereo microscope the tail region of the pancreas was visualized and the main pancreatic duct was ligated carefully with 6-0 Prolene suture without damaging the left portal vein that separates the splenic lobe and gastroduodenal part of the pancreas.
Any mice suffering damage to any underlying blood vessels were excluded from the experiment. The pancreas was examined 24 hrs after ligation. A 100-125 gm portion of the tail region of the pancreas was used for biochemical assays and histological staining.
Mice were subjected to caerulein-induced pancreatitis by intraperitoneal injection of caerulein (50 μg/kg) (Tocris; catalog #6264) every hour for a total of 6 injections as previously described (85) .
Blood amylase assay. The serum amylase concentration was measured by a colorimetric method after reacting with substrate using the Phadebas amylase test tablet (Magle Life Sciences, Cambridge, MA) and Tecan-infinite M200 Pro plate reader (1) .
Myeloperoxidase (MPO) assay. MPO was measured using previously described methods with modifications (1). To calculate the mUnits of MPO/mg of protein the protein concentration of the supernates were measured using the Micro BCA Protein Assay Kit (Thermo Scientific Kit; catalog #23235).
Hematoxylin and Eosin (H&E) staining. In Yoda1-mediated pancreatitis the body region of the pancreas was used for H&E staining (1) and in partial duct ligation mediated pancreatitis the tail region of the pancreas was used. The histological score was calculated from the pathological parameters e.g., tissue edema, neutrophil infiltration, necrosis and hemorrhage with minimum to a severe scoring range of 0-3, 0-3, 0-7 and 0-7, respectively (91) . The scores from all parameters were summed to obtain a total histological score. ] i in pancreatic acini with or without treatment with the cytoplasmic PLA2 blocker AACOCF3 (30 µM) and secretory PLA2 blocker YM26734 (10 µM). YM26734 and AACOCF3 were pre-incubated 10 minutes before application of Yoda1. The transient calcium peaks were measured from signals obtained between 1 to 3 minutes (yellow bar) and sustained calcium peaks were measured from signals between 5.5 to 6.5 minutes (pink bar). Data represent the averages of 36-58 cells. Values were expressed as the means±SEM and mean differences between multiple groups were analyzed by one-way ANOVA with the Tukey's multiple comparison. P values <0.05 were considered significant. *P ≤ 0.05; *** P ≤ 0.001; ****P ≤ 0.0001.
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